Selected article for: "blood pressure and disease virus"
Author: Sellegounder, Durai; Zafari, Parisa; Rajabinejad, Misagh; Taghadosi, Mahdi; Kapahi, Pankaj
Title: Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis
  • Cord-id: jihzpsmh
  • Document date: 2021_5_24
    • ID: jihzpsmh
    Snippet: Coronavirus Disease 2019 (COVID-19), caused by the novel virus SARS-CoV-2, is often more severe in older adults. Besides age, other underlying conditions such as obesity, diabetes, high blood pressure, and malignancies, which are also associated with aging, have been considered risk factors for COVID-19 mortality. A rapidly expanding body of evidence has brought up various scenarios for these observations and hyperinflammatory reactions associated with COVID-19 pathogenesis. Advanced glycation e
    Document: Coronavirus Disease 2019 (COVID-19), caused by the novel virus SARS-CoV-2, is often more severe in older adults. Besides age, other underlying conditions such as obesity, diabetes, high blood pressure, and malignancies, which are also associated with aging, have been considered risk factors for COVID-19 mortality. A rapidly expanding body of evidence has brought up various scenarios for these observations and hyperinflammatory reactions associated with COVID-19 pathogenesis. Advanced glycation end products (AGEs) generated upon glycation of proteins, DNA, or lipids play a crucial role in the pathogenesis of age-related diseases and all of the above-mentioned COVID-19 risk factors. Interestingly, the receptor for AGEs (RAGE) is mainly expressed by type 2 epithelial cells in the alveolar sac, which has a critical role in SARS-CoV-2-associated hyper inflammation and lung injury. Here we discuss our hypothesis that AGEs, through their interaction with RAGE amongst other molecules, modulates COVID-19 pathogenesis and related comorbidities, especially in the elderly.

    Search related documents:
    Co phrase search for related documents
    • accessory protein and acute lung injury: 1
    • accessory protein and acute respiratory syndrome sars: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accessory protein and adaptor molecule: 1
    • accumulation production and active form: 1
    • accumulation production and acute ards respiratory distress syndrome: 1
    • accumulation production and acute lung injury: 1, 2
    • accumulation production and acute respiratory syndrome sars: 1, 2, 3, 4
    • accumulation production and adaptor molecule: 1
    • accumulation production and liver kidney: 1, 2, 3
    • ace angiotensin convert enzyme and acute respiratory syndrome sars: 1
    • active form and acute ards respiratory distress syndrome: 1
    • active form and acute respiratory syndrome sars: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • active form and liver kidney: 1
    • acute ards respiratory distress syndrome and adenine nadph dinucleotide phosphate: 1
    • acute ards respiratory distress syndrome and liver kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome cause and liver kidney: 1
    • acute lung injury and adenine nadph dinucleotide phosphate: 1
    • acute lung injury and liver kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory syndrome sars and adaptor molecule: 1